Dostinex
Dostinex

2.59
For patients managing hormonal and menopause conditions, this generic medicine regulates dopamine receptors in the pituitary gland to balance specific hormone levels.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Cabergoline
Reference Brand
Cabergoline
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones, Hormone Therapy
Product Category
Dopamine Agonist
Pharmacological Class
Ergot Derivative
Clinical Indications
Manufacturer Description
Intended to relieve hyperprolactinemia symptoms to support normal reproductive cycles and target anterior pituitary secretion.
Mechanism of Action
Acts as a selective agonist at dopamine D2 receptors on pituitary lactotroph cells, suppressing hormone release pathways.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
7–14 days
Contraindications
Uncontrolled hypertension, History of cardiac valvular disorders, Hepatic impairment
Severe Adverse Events
Cardiac valvulopathy — requires immediate medical attention, Psychotic episodes — requires immediate medical attention
Common Side Effects
Nausea, Headache, Dizziness
Uncommon Side Effects
Fatigue, Constipation, Postural hypotension
Drug Interactions
Metoclopramide, Phenothiazines, Antihypertensives
Pregnancy Safety Warnings
TGA Category B: Use with caution. Breastfeeding: Suppresses lactation.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Dostinex is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Hair Loss Treatment AU - Avodart Price